Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  The Lancet

• Publication date

  2002-06-22

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(02)09089-XPMID 12090978
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance.

  2001cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview.

  2000cited by this paper
• Myocardial infarction redefined--a consensus document of The Joint European Society of Cardiology/American College of Cardiology Committee for the redefinition of myocardial infarction.

  2000cited by this paper
• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria

  1999cited by this paper
• Report of the expert committee on the diagnosis and classification of diabetes mellitus.

  1999cited by this paper
• Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in

  1999cited by this paper
• Screening for impaired glucose tolerance. Results from a population-based study in 21,057 individuals.

  1999cited by this paper
• Admission plasma glucose. Independent risk factor for long-term prognosis after myocardial infarction even in nondiabetic patients.

  1999cited by this paper
• The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years.

  1999cited by this paper
• Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe.

  1999cited by this paper
• Glucose tolerance and resistance to insulin-stimulated glucose uptake in men aged 70 years in relation to size at birth

  1998cited by this paper
• Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation

  1998cited by this paper
• Isolated Postchallenge Hyperglycemia and the Risk of Fatal Cardiovascular Disease in Older Women and Men: The Rancho Bernardo Study

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

  1998cited by this paper
• Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

  1998cited by this paper
• Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus

  1997cited by this paper
• Case-control study of sudden infant death syndrome in Scotland, 1992-5

  1997cited by this paper
• Angiographic findings and outcome in diabetic patients treated with thrombolytic therapy for acute myocardial infarction: the GUSTO-I experience.

  1996cited by this paper
• The Prognostic Value of Blood Glucose in Diabetic Patients with Acute Myocardial Infarction

  1996cited by this paper
• Capillary Blood on Filter Paper for Determination of HbA1c by Ion Exchange Chromatography

  1996cited by this paper
• Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: A statewide study

  1995cited by this paper
• Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group.

  1995cited by this paper
• Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year.

  1995cited by this paper
• The Relation of Diabetes to the Severity of Acute Myocardial Infarction and Post-Myocardial Infarction Survival in Mexican-Americans and Non-Hispanic Whites: The Corpus Christi Heart Project

  1994cited by this paper
• Fasting blood sugar level: a determinant for in-hospital outcome in patients with first myocardial infarction and without glucose intolerance.

  1993cited by this paper
• The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus.

  1993cited by this paper
• In-Hospital Prognosis of Ppatients With Fasting Hyperglycemia After First Myocardial Infarction

  1991cited by this paper
• Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus.

  1989cited by this paper
• Myocardial infarction in patients with diabetes mellitus.

  1988cited by this paper
• The impact of diabetes on survival following myocardial infarction in men vs women. The Framingham Study.

  1988cited by this paper
• Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction.

  1986cited by this paper
• Coronary-heart-disease risk and impaired glucose tolerance. The Whitehall study.

  1980cited by this paper
• Glucose tolerance and coronary heart disease: Helsinki policemen study.

  1979cited by this paper
• West Indian one-year-olds. A comparative analysis of health and service utilisation.

  1967cited by this paper

• Dual-Mode sensing patch for visual glucose detection enabled by an AuNPs-PAM nanozyme cascade

  2026cites this paper
• Glycosylated Hemoglobin (HbA1C) and Its Prognostic Value in AcuteCoronary Syndrome

  2025cites this paper
• High-Risk Plaque Characteristics in Patients with Suspected Stable Coronary Artery Disease and Impaired Glucose Tolerance: A Coronary Computed Tomography Angiography Study

  2025cites this paper
• Impaired microcirculation in the skin and subclinical atherosclerosis in individuals with dysglycaemia in a large population-based cohort

  2025cites this paper
• Glycemic variability of glycated hemoglobin in patients with type 2 diabetes mellitus and the risk of cardiovascular diseases: a latest systematic review and meta-analysis

  2025cites this paper
• Exploring the Protective Effects of Schisandrin A and Schisandrin B Against Diabetic Cardiomyopathy With a Possible Mechanism Involving Complement Inhibition

  2025cites this paper
• Association of fasting blood glucose with in-hospital mortality in acute coronary syndrome patients with different glycemic statuses: Findings from the CCC-ACS project.

  2025cites this paper
• Dual Roles of HbA1c Variability and Body Composition for Cardiovascular Risk: A Cohort Study of 8224 Adults With Type 2 Diabetes Mellitus

  2025cites this paper
• Impact of Dapagliflozin on Cardiometabolic Outcomes After Acute Myocardial Infarction According to Baseline Glycemic Status and Body Mass Index: Subanalyses of the DAPA‐MI Trial

  2025cites this paper
• The recent renewed interest among cardiologists in detecting and preventing diabetes is welcomed

  2025cites this paper
• A Study on Prognostic Value of Admission Glycosylated Hemoglobin and Blood Glucose in Nondiabetic Patients with ST‐Segment Elevation Myocardial Infarction

  2025cites this paper
• Incidental hyperglycemia and myocardial infarction risk in non-diabetic patients in the emergency department: A retrospective cohort analysis

  2025cites this paper
• Trends in the prevalence of cardiovascular disease, defined as ECG abnormalities and/or self-reported events, in Mauritius between 1987 and 2021: analysis of data from seven large population-based surveys

  2025cites this paper
• A Review of Prediabetes: Diagnosis, Consequences and Interventions

  2025cites this paper
• The Association of Insulin Sensitivity, Secretion, and Clearance With Subclinical Atherosclerosis in Middle‐Aged Adults Without Diabetes: A Cross‐Sectional Analysis of the SCAPIS Cohort

  2025cites this paper
• Impact of glucometabolic status on type 4a myocardial infarction in patients with non–ST-segment elevation myocardial infarction: the role of stress hyperglycemia ratio

  2025cites this paper
• Rôle de l’hyperglycémie dans la mortalité à la phase aiguë d’un accident vasculaire cérébral au CHU de Cocody, Abidjan Côte d’Ivoire

  2025cites this paper
• Cardiovascular disease and beta-cell function at diagnosis of serologically defined adult-onset type 1 and type 2 diabetes in two Swedish cohorts 15 years apart

  2025cites this paper
• Diagnosis and management of type 2 diabetes mellitus in patients with ischaemic heart disease and acute coronary syndromes - a review of evidence and recommendations

  2025cites this paper
• Preoperative hyperglycemia and postoperative adverse events in geriatric hip fracture surgery: Glycemic thresholds and exposure persistence.

  2025cites this paper
• Facile fabrication of a non-enzymatic electrochemical sensor based on poly(o-phenylenediamine)/Ni(OH)2–NiOOH hybrids for the detection of myo-inositol

  2025cites this paper
• Impact of glycaemic status on the cardiac effects of empagliflozin when initiated immediately after myocardial infarction: A post‐hoc analysis of the EMMY trial

  2024cites this paper
• Edge-functionalized graphene quantum dot as a nano-biosensor for simultaneous detection of glucose, galactose and lactose

  2024cites this paper
• Low Levels of Adropin Predict Adverse Clinical Outcomes in Outpatients with Newly Diagnosed Prediabetes after Acute Myocardial Infarction

  2024influential citation
• Elevated Glucose on Admission Was an Independent Risk Factor for 30-Day Major Adverse Cardiovascular Events in Patients with STEMI but Not NSTEMI

  2024cites this paper
• Bibliometric analysis of ST elevation myocardial infarction research from 1933 to 2023: Focus on top 100 most-cited articles.

  2024cites this paper
• Complications cardiaques du patient diabétique (maladie coronaire, cardiomyopathie, neuropathie autonome cardiovasculaire) : prévention et traitement

  2024cites this paper
• Dysglycaemia in cardiovascular disease: what's the best glycaemic risk predictor?

  2024cites this paper
• A machine learning tool for identifying newly diagnosed heart failure in individuals with known diabetes in primary care

  2024cites this paper
• Structured diabetes care routines in cardiac rehabilitation are associated with increased diabetes detection and improved treatment after myocardial infarction: a nationwide observational study

  2024cites this paper
• Preliminary investigation of the effect of non-cardiac surgery on intraoperative islet and renal function: a single-center prospective cohort study

  2024cites this paper
• The glycosylated hemoglobin level and the severity of cardiovascular involvement in patients with the first episode of acute coronary syndrome

  2024cites this paper
• The effect of Empagliflozin on echocardiographic parameters in diabetic patients after acute myocardial infarction: A systematic review and meta-analysis with trial sequential analysis

  2024cites this paper
• Prevalence of glucose metabolism disorders and its association with left atrial remodelling before and after catheter ablation in patients with atrial fibrillation

  2023cites this paper
• Glucose variability: a new risk factor for cardiovascular disease

  2023cites this paper
• Glucose determination in human serum by applying inner filter effect quenching mechanism of upconversion nanoparticles

  2023cites this paper
• Microvascular and Endothelial Dysfunction in Prediabetes

  2023cites this paper
• The legacy effect in early-stage diabetes: Don't stay by me, cardiovascular disease!

  2023cites this paper
• Arterial stiffness and subclinical atherosclerosis in the coronary arteries at different stages of dysglycaemia

  2023cites this paper
• Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury

  2023cites this paper
• Long-term increase in fasting blood glucose is associated with increased risk of sudden cardiac arrest

  2023cites this paper
• Prediabetes is Associated with Worse Long-Term Outcomes in Young Patients with Acute Coronary Syndrome

  2023cites this paper
• Prevalence of atherosclerosis in individuals with prediabetes and diabetes compared to normoglycaemic individuals—a Swedish population-based study

  2023cites this paper
• 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes.

  2023cites this paper
• Design and rationale of the myocardial infarction and new treatment with metformin study (MIMET) - Study protocol for a registry-based randomised clinical trial.

  2023cites this paper
• American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm - 2023 Update.

  2023cites this paper
• SOdium-glucose CO-transporter inhibition in patients with newly detected Glucose Abnormalities and a recent Myocardial Infarction (SOCOGAMI).

  2022cites this paper
• A diabetes mellitus szűrési és kezelési tendenciáinak vizsgálata általános kardiológiai betegekben

  2022cites this paper
• Metabolic disorders in patients with impaired glucose tolerance, with or without underlying ischaemic heart disease

  2022cites this paper
• Measures of Insulin Resistance as a Screening Tool for Dysglycemia in Patients With Coronary Artery Disease: A Report From the EUROASPIRE V Population.

  2022cites this paper
• Secondary Prevention after Myocardial Infarction: What to Do and Where to Do It

  2022cites this paper
• In Hospital Outcome in First Attack of Acute Coronary Syndrome and Association of Glycated Haemoglobin A1c Level

  2022cites this paper
• Admission glucose as a prognostic marker for all-cause mortality and cardiovascular disease

  2022cites this paper
• The effect of stress hyperglycemıa seen ın acute ST-segment elevatıon ın myocardıal ınfarctıon on ın-hospıtal mortalıty.

  2022cites this paper
• Plasma mannose as a novel marker of myocardial infarction across different glycaemic states: a case control study

  2022cites this paper
• American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update.

  2022cites this paper
• Long-term prognosis after a first myocardial infarction: eight years follow up of the case-control study PAROKRANK

  2022cites this paper
• Diabetes, kardiovaskuläres Risiko und koronare Herzkrankheit

  2022cites this paper
• 1-h post-load plasma glucose for detecting early stages of prediabetes.

  2022cites this paper
• Association between glycosylated hemoglobin, diabetes mellitus, and preoperative deep vein thrombosis in patients undergoing total joint arthroplasty: a retrospective study

  2022cites this paper
• Positive Regulation of Endothelial Tom70 by Metformin as a New Mechanism Against Cardiac Microvascular Injury in Diabetes.

  2022cites this paper
• Mannose-binding lectin does not explain the dismal prognosis after an acute coronary event in dysglycaemic patients. A report from the GAMI cohort

  2022cites this paper
• Glycemic gap and the outcome of diabetic patients presenting with acute coronary syndrome

  2022cites this paper
• Assessing myocardial infarction severity from the urban environment perspective in Wuhan, China.

  2022cites this paper
• Glucose tolerance and markers of myocardial injury after an acute coronary syndrome: predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test

  2022cites this paper
• Glucose Tolerance and cardiovascular outcomes after an acute coronary syndrome – Predictive role of the 1-h plus 2-h plasma glucose at the oral glucose tolerance test

  2022cites this paper
• Sonochemically synthesized mesoporous cobalt oxide nanoparticles for luminol-enhanced chemiluminescence sensing

  2022cites this paper
• Secondary prevention in diabetic and nondiabetic coronary heart disease patients: Insights from the German subset of the hospital arm of the EUROASPIRE IV and V surveys

  2022cites this paper
• HbA1c Screening for Diabetes in Patients with Acute Coronary Syndrome: A Worthwhile Test or a Pitfall?

  2021cites this paper
• Impact of prediabetes on cardiovascular disease risk in patients with acute myocardial infarctions

  2021cites this paper
• Preoperative risk factors for deep vein thrombosis in knee osteoarthritis patients undergoing total knee arthroplasty.

  2021cites this paper
• Glucose-lowering therapy in patients undergoing percutaneous coronary intervention.

  2021cites this paper
• COVID-19, Hyperglycemia, and New-Onset Diabetes

  2021cites this paper
• The role of traditional Chinese medicine in the treatment of cognitive dysfunction in type 2 diabetes.

  2021cites this paper
• ЕВРАЗИЙСКИЕ РЕКОМЕНДАЦИИ ПО ПРОФИЛАКТИКЕ И ЛЕЧЕНИЮ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ У БОЛЬНЫХ С ДИАБЕТОМ И ПРЕДИАБЕТОМ (2021)

  2021cites this paper
• Androgen receptor polymorphism, testosterone levels, and prognosis in patients with acute myocardial infarction

  2021cites this paper
• Metabolic Abnormalities, Dietary Risk Factors and Nutritional Management in Amyotrophic Lateral Sclerosis

  2021cites this paper
• Approach to the patient: Early post-renal transplant hyperglycemia

  2021cites this paper
• Screening and identification of potential protein biomarkers for the early diagnosis of acute myocardial infarction

  2021cites this paper
• Admission Glucose Levels and Associated Risk for Heart Failure After Myocardial Infarction in Patients Without Diabetes

  2021cites this paper
• Benefits of sodium glucose cotransporter 2 inhibitors across the spectrum of cardiovascular diseases

  2021cites this paper
• Heart failure at the crossroads of cardiology and diabetology.

  2021cites this paper
• Admission hyperglycemia and all-cause mortality in diabetic and non-diabetic patients with acute myocardial infarction: a tertiary center analysis

  2021cites this paper
• Cardiovascular impact of new drugs (GLP-1 and gliflozins): the ABCD position statement

  2021cites this paper
• Admission glucose level and short-term mortality in older patients with acute myocardial infarction: results from the KORA Myocardial Infarction Registry

  2021cites this paper
• The Relationship Between Pre Procedural Glucose and Contrast Induced Nephropathy in the Patients with Acute Coronary Syndrome Undergoing Coronary Angiography

  2021cites this paper
• The Relationship Between Pre Procedural Glucose and Contrast Induced Nephropathy in the Patients with Acute Coronary Syndrome Undergoing Coronary Angiography

  2021cites this paper
• Long-term prognosis in patients with acute myocardial infarction and newly detected glucose abnormalities: predictive value of oral glucose tolerance test and HbA1c

  2021cites this paper
• Prevalence of Prediabetes in Patients with Acute Coronary Syndrome and Its Relation to In-Hospital Clinical Outcome

  2021influential citation
• Oral Glucose Tolerance Test as a Tool for Patient Improvement After Percutaneous Coronary Intervention

  2021cites this paper
• Latent disorders of carbohydrate metabolism in patients with acute

  2021cites this paper
• Saving time by replacing the standardised two-hour oral glucose tolerance test with a one-hour test: Validation of a new screening algorithm in patients with coronary artery disease from the ESC-EORP EUROASPIRE V registry.

  2021cites this paper
• Phenotyping the Prediabetic Population—A Closer Look at Intermediate Glucose Status and Cardiovascular Disease

  2021influential citation
• Patient delay prior to care-seeking in acute myocardial infarction during the outbreak of the coronavirus SARS-CoV2 pandemic.

  2021cites this paper
• IGF-1 is not related to long-term outcome in hyperglycemic acute coronary syndrome patients

  2021cites this paper
• The Relationship Between Pre Procedural Glucose and Contrast Induced Nephropathy in the Patients with Acute Coronary Syndrome Undergoing Coronary Angiography

  2021cites this paper
• Artificial Intelligence Uncovered Clinical Factors for Cardiovascular Events in Myocardial Infarction Patients with Glucose Intolerance

  2020cites this paper
• The Significance of Dynamics of ST Segment Changes When Assessing the Effectiveness of Mechanical Reperfusion of the Myocardium in Hyperglycaemic Patients with Acute Myocardial Infarction with Persistent ST-Segment Elevation

  2020cites this paper
• Postprandial Increase in Glucagon-like Peptide-1 is Blunted in Severe Heart Failure.

  2020cites this paper
• The clinical characteristics and outcomes of patients with diabetes and secondary hyperglycaemia with coronavirus disease 2019: A single‐centre, retrospective, observational study in Wuhan

  2020cites this paper